You've heard about a clinical trial that might help your child. Or you've been told there's no approved treatment yet, but research is happening. Either way, you're trying to figure out where to start.

ClinicalTrials.gov is the central registry. Every trial in the U.S. that receives federal funding is required to post there. It's comprehensive, which also makes it overwhelming. The search interface assumes you already know what phase means, what eligibility criteria look like, and how to distinguish a reputable center from a less established one.

This guide walks you through how to search the database, what the trial phases mean for your child, where the major research is concentrated by condition, and which questions to ask before you enroll. By the end, you'll have a clear process for evaluating whether a trial is the right fit.

How to Search ClinicalTrials.gov

Start at ClinicalTrials.gov. The basic search bar accepts condition names, but the advanced search gives you control over what you're seeing.

Use the Advanced Search filters:

• Condition or disease: Enter the specific diagnosis: autism spectrum disorder, cerebral palsy, Down syndrome. The database uses medical terminology, so if your initial search returns nothing, try the clinical name rather than the colloquial one.
• Recruitment status: Set this to "Recruiting" or "Not yet recruiting." Trials marked "Completed" or "Terminated" won't accept new participants.
• Age: Specify your child's age range. Pediatric trials often have narrow age bands tied to developmental stages: 2-5 years, 6-12 years.
• Location: Filter by state or distance from your ZIP code. Most trials require in-person visits.

Read the eligibility criteria carefully. Every trial lists inclusion and exclusion criteria. Inclusion criteria are what your child must have: diagnosis, age range, symptom severity. Exclusion criteria are disqualifying factors: other medications, co-occurring conditions, recent surgeries. If your child doesn't meet the inclusion criteria or hits an exclusion, the trial won't accept them. Contact information is listed on each trial page. Call before you spend time traveling.

Check the study design. Some trials are observational: researchers collect data without changing treatment. Others are interventional: participants receive a new drug, device, or therapy. Observational trials carry less risk but offer no treatment. Interventional trials offer access to therapies not yet approved, but come with unknowns.

What Trial Phases Mean

Clinical trials move through phases. Each phase answers a different question, and the risks change depending on where the trial sits in that sequence.

Phase 1: Safety in small groups. These trials test whether a treatment is safe in humans. They typically involve 20-80 participants, last several months, and focus on dosage and side effects. Phase 1 trials carry the highest uncertainty. The treatment has never been tested in people before. They're rarely appropriate for children unless no other options exist.

Phase 2: Does it work? Once a treatment clears Phase 1, Phase 2 tests whether it's effective. These trials involve 100-300 participants, often include a control group, and last from several months to two years. Phase 2 is where researchers start to see whether the treatment changes outcomes. The risks are lower than Phase 1, but the treatment hasn't been proven yet.

Phase 3: Comparison to standard care. Phase 3 trials involve hundreds or thousands of participants, compare the new treatment to the current standard, and are the final step before FDA approval. These trials are more established. Researchers already have evidence the treatment works and is relatively safe. Phase 3 is often the most appropriate entry point for children.

Phase 4: Post-approval monitoring. After FDA approval, Phase 4 trials track long-term effects in large populations. These trials carry the lowest risk because the treatment is already approved, but they help identify rare side effects or new uses.

If you're looking at a Phase 1 or early Phase 2 trial, ask why. For most families, Phase 3 trials offer a better balance of access and safety.

Major Research Centers by Condition

Clinical trials cluster at academic medical centers with established research programs. Knowing where the largest concentrations are can help you target your search.

Autism: As of early 2025, 48 autism trials are actively recruiting in the U.S. The highest concentration is in California, Florida, Ohio, and New York. Major centers include UCLA, Stanford, University of California San Francisco, Cincinnati Children's Hospital, and New York Presbyterian.

Cerebral Palsy: Worldwide, 377 CP trials are recruiting, with 84 in the U.S. Research is less geographically concentrated than autism. Trials are spread across university hospitals and rehabilitation centers. Boston Children's, Gillette Children's, Kennedy Krieger Institute, and Texas Children's Hospital run the most consistent CP trial pipelines.

Down Syndrome, Fragile X, Rare Genetic Conditions: Trials for less common diagnoses often run through consortiums: groups of hospitals pooling participants to reach enrollment numbers. NIH-funded consortiums include the Rare Diseases Clinical Research Network and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, known as NICHD. If ClinicalTrials.gov returns few results for your child's condition, search for the consortium name and see which hospitals are participating sites.

If you're not near a major center, some trials allow remote participation for follow-up visits or use telemedicine for check-ins. Ask whether travel support is available. Some federally funded trials cover transportation or lodging.

Assessing Safety and Fit

Before you commit, these are the questions that matter.

What are the risks compared to what my child is already doing? Ask for specifics: Is this treatment more invasive than the therapies your child currently receives? Are there side effects observed in earlier phases? How often will visits require blood draws, imaging, or sedation? A trial that involves monthly blood work is a different commitment than one that requires quarterly check-ins.

What happens if the treatment isn't working? Trials are voluntary. You can withdraw at any time, for any reason, without penalty. But ask what withdrawal looks like in practice. Will your child be weaned off the intervention gradually? Will follow-up visits continue to monitor for delayed effects? Clarify the exit process before you enroll.

What's the comparison group? If the trial is randomized, your child may receive the experimental treatment, the standard treatment, or a placebo. Ask what the randomization ratio is. A 2:1 ratio means two participants get the treatment for every one who gets the placebo. Ask whether there's a crossover: participants who receive the placebo in the first phase may get the treatment in the second. If your child needs active treatment now, a placebo-controlled trial may not be appropriate.

Who's funding this? Industry-sponsored trials, funded by pharmaceutical or device companies, often move faster and have more resources, but the company has a financial interest in a positive outcome. Federally funded trials from NIH or CDC are slower but have no profit motive. Both are legitimate. Just understand the structure.

How will I know what's happening? Ask how often you'll receive updates, whether you'll have access to your child's data during the trial, and what happens if the trial ends early. Some trials are stopped early for safety reasons. Others are stopped because the treatment works so well that withholding it from the control group becomes unethical. Both are possibilities.

What does insurance cover? Clinical trials are required to cover the cost of the experimental treatment, but routine care may still be billed to your insurance: doctor visits, lab work, imaging. Ask for a breakdown of what the trial covers and what you're responsible for. Some trials cover all costs. Others cover only the investigational drug or device.

What Informed Consent Means

Before your child enrolls, you'll sign an informed consent form. It's a legal document, but it's also the place where the trial's risks, benefits, and unknowns are spelled out in full.

Read the whole thing. It's long, often 15 to 30 pages, but it contains everything the researchers know about what could go wrong and what they hope will go right. Pay attention to the sections on risks, the procedures your child will undergo, and your rights as a participant.

You're signing for your child, which means you're weighing their immediate safety against the possibility that this trial helps future families. The consent form should give you space to ask questions before you sign. If it doesn't feel like that space exists, that's a red flag.

You can withdraw consent at any time. Signing doesn't lock you in. If the trial isn't working, if the visits are too disruptive, if your child is struggling, you can stop. The form will say this explicitly. Make sure you see it in writing.

Barriers Worth Knowing About

Even when a trial looks like a good fit on paper, logistical and systemic barriers can make participation difficult.

Travel and time off work. If the nearest trial site is two hours away and visits happen every two weeks, you're committing to a significant travel schedule. Some families make it work. Others can't. Ask whether the trial offers travel reimbursement, lodging support, or virtual visit options for follow-ups.

Exclusionary criteria. Many trials exclude children who are on certain medications, have co-occurring conditions, or don't meet narrow symptom thresholds. These criteria exist for scientific reasons. Researchers need a homogeneous group to measure the treatment's effect. But they also mean that children with complex presentations are often left out.

Distrust of researchers. Historically, marginalized communities have been subjected to unethical research practices. That history hasn't been repaired, and it affects participation today. If you're skeptical of a trial's motives, that skepticism is justified. Ask for transparency, ask for data, and ask to speak with other families who've participated.

Physical inaccessibility. Some trial sites aren't equipped for children with mobility disabilities. If your child uses a wheelchair, if they need a lift-equipped exam table, if they require sensory accommodations, ask whether the facility can provide that before you commit.

What This Looks Like in Practice

You search ClinicalTrials.gov for your child's condition, filter by recruiting status and age, and find three trials within 50 miles. One is Phase 1, testing a new drug for the first time in humans. One is Phase 3, comparing an established therapy to standard care. One is observational: tracking developmental outcomes without changing treatment.

You read the eligibility criteria. Your child meets the inclusion for the Phase 3 trial but hits an exclusion on the observational study. You call the contact number on the Phase 3 listing and ask about visit frequency, randomization ratio, and what happens if your child is assigned to the control group.

The coordinator walks you through the schedule: monthly visits for six months, then quarterly follow-ups for a year. The randomization is 3:1, meaning three out of four participants get the treatment. There's a crossover at six months. You ask about travel support. They offer mileage reimbursement and can schedule visits around your work hours.

You ask to see the informed consent form before you commit to a screening visit. They send it. You read it. It lists the known side effects from Phase 2, the procedures your child will undergo, and your right to withdraw at any time. You talk to your partner. You ask your child's pediatrician what they think. You decide whether this is the right move for your family right now.

That's the process. It's not simple, but it's navigable once you know what you're looking for.

Staying Informed

ClinicalTrials.gov updates daily. Trials open, close, and change recruitment status regularly. If you don't find a trial today, search again in three months.

Set up a saved search with your criteria: condition, age, location. The site will email you when a new trial matching your filters is posted.

If your child has a rare condition, join the patient advocacy organization. Many rare disease groups maintain trial trackers and have direct relationships with research teams. They'll often know about trials before they're publicly listed.

You don't need a medical degree to evaluate a trial. You need the questions, the process, and the knowledge that you can walk away if it's not right. This is your decision, and the researchers owe you clarity before you sign.